Business Context and Reporting Period
Prestige Consumer Healthcare Inc. (PBH) filed a Form 8-K on July 15, 2026, reporting the entry into a material definitive agreement. The filing details a debt issuance by Prestige Brands, Inc., a wholly owned subsidiary of the Company.
Key Financial Metrics
- Debt Issuance: $400.0 million aggregate principal amount of 6.250% senior notes due 2034.
- Interest Payments: Payable semi-annually on January 15 and July 15, commencing January 15, 2027.
- Maturity Date: July 15, 2034.
- Security Status: Senior unsecured obligations of Prestige Brands, guaranteed on an unsecured senior basis by the Company and certain domestic restricted subsidiaries.
- Revenue, Profit, and Cash Flow: The filing text does not provide a clear value for these metrics as this is a transactional report, not a periodic financial statement.
Material Changes and Terms
The Company has increased its debt load by $400.0 million through a private offering exempt from registration under Rule 144A and Regulation S. The notes include specific redemption and change of control provisions:
- Redemption: The Company may redeem notes on or after July 15, 2029, at set prices. Prior to this date, redemption is possible at 100% of principal plus a make-whole premium. Up to 40% of the principal may be redeemed prior to July 15, 2029, using proceeds from certain equity offerings.
- Change of Control: In the event of a Change of Control, the Company must offer to purchase the notes at 101% of the aggregate principal amount plus accrued interest.
Guidance, Risks, and Covenants
The Indenture imposes significant financial covenants that restrict the Company's ability to:
- Incur, assume, or guarantee additional indebtedness.
- Pay dividends or redeem/repurchase capital stock.
- Make restricted payments or incur liens.
- Redeem debt junior to the notes, sell assets, or enter into mergers and affiliate transactions.
Events of Default: Include nonpayment of principal or interest, breach of agreements, defaults on other indebtedness, judgments against the Company, unenforceable guarantees, and bankruptcy or insolvency events.
Investor Verification Checklist
- Verify the use of proceeds from the $400.0 million note issuance.
- Review the full text of the Indenture (Exhibit 4.1) for specific covenant exceptions and qualifications.
- Assess the impact of the new 6.250% interest rate on the Company's overall cost of capital and interest coverage ratios.
- Confirm the list of guarantors and the extent of the guarantee coverage.